Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/3/23 17:03 | 12/31/22 | JAGX | Health | Drug | Pharmaceutical Preparations | Wolin Jonathan S. | CA | O | Chief of | P | 0 | 0.0300 | 0 | 0 | 5 | 7 | D | ||||||||||||||
3/30/22 21:32 | 9/13/21 | JAGX | Health | Drug | Pharmaceutical Preparations | Lizak Carol R. | CA | O | CFO | P.d | 20 | 2.51 | 0 | 8 | New | 8 | I | ||||||||||||||
3/30/22 21:26 | 9/13/21 | JAGX | Health | Drug | Pharmaceutical Preparations | Conte Lisa A | CA | DO | CEO,P | P.d | 20 | 2.51 | 0 | 8 | 999% | 8 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |